All Articles

With its 12th straight annual dividend increase, The First Bancorp shines. But does this reflect the strength of community banking or mask regional risks?

Beyond charity, a $7.2M Central Florida project reveals a replicable model where public, private, and non-profit sectors unite to build economic stability.

uniQure's upsized $259M offering signals massive investor confidence, fueling its Huntington's therapy, AMT-130, and reshaping the gene therapy landscape.

As rising property values outpace federal coverage, Neptune Flood's new $15M limit signals a pivotal shift in how America protects its most valuable assets.

A century-old, employee-owned company invests nearly $800 million to secure jobs and slash emissions, revealing a blueprint for American industrial renewal.

As Ottawa rolls out tough new bail laws to combat retail theft, Halifax businesses wonder if it's enough to tackle a crisis fueled by addiction and resource gaps.

A Pennsylvania firm's new 3D-printed titanium cervical cage has been used in a patient for the first time, heralding a new era of spinal implants.

With court approval secured, First Capital's $9.4B sale to KingSett and Choice Properties is nearly complete, signaling a major consolidation in Canada's prized grocery-anchored real estate market.

Wise's stellar FY26 results show more than just growth. They reveal a durable strategy of infrastructure, regulation, and customer value in a volatile market.

As McGrath sets its Q2 earnings date, investors watch to see if its tech rental boom can offset modular market headwinds and protect a 35-year dividend streak.

New data on a once-weekly drug and a novel combination therapy signal a major shift in treating achondroplasia, moving the focus from height to quality of life.

The Specialty Food Association's new board blends seasoned veterans with innovators from Misfits Market and Seal the Seasons, signaling a strategic shift.

A Singaporean tech firm's new certification reveals a seismic shift. Competitive advantage is no longer about who has AI, but who can prove it's trustworthy.

A sharp 641 million share increase in bets against the market reveals growing investor anxiety amid economic headwinds. What does this signal for your portfolio?

Hand & Stone appoints former Subway CEO Carrie Walsh to lead its next chapter. Can her fast-food playbook scale accessible luxury in the booming wellness economy?

Conectiv's new MyLife Wellness line enters the crowded health market, but it's a desperate play by a parent company facing steep losses and 'going concern' warnings.

A startling analysis reveals 74% of Durham's serious crashes occur on just 10% of its streets. This data is now the backbone of a city-wide strategy to re-engineer risk.

With a fresh $50M, Patronus AI is moving beyond static tests, building simulated worlds where AI agents can learn, fail, and improve safely.

CEMA's 47th awards showcase a savvy hybrid strategy, blending a digital-first webcast with key broadcast partnerships to amplify underrepresented voices.

As pharma giants battle with blockbuster drugs, one company is betting on a simple, non-systemic hydrogel. Is this the future of weight management?